Search Results - "Hong, Phillip"

Evaluating Complications of Chronic Sinusitis by Breslin, Adam, Guo, Uta, Pereyra, Charles A., Hong, Phillip, Melville, Laura

“…Chronic sinusitis is a relatively common diagnosis throughout the US. In patients with an otherwise unremarkable medical history the treatment is typically…”
Get full text

PROMPT INITIATION OF THERAPIES PRIOR TO DIAGNOSIS IN A PATIENT WITH SUSPECTED GIANT CELL MYOCARDITIS COMPLICATED BY CARDIOGENIC SHOCK by Rizk, Alexander A., Singam, Sarma, Lam, Phillip Hong

Get full text

HEMOCHROMATOSIS DEBUT AFTER LIVER TRANSPLANT: A RARE CASE OF CARDIOGENIC SHOCK by Ros, Marta Lorente, Li, Zhi, Bering, Patrick T., Lam, Phillip Hong

Get full text

GIANT CELL MYOCARDITIS: A STRAIGHTFORWARD DIAGNOSIS? by Fraser, Ethan J., Culver, Austin, Lam, Phillip Hong, Hofmeyer, Mark, Gupta, Richa, Sheikh, Farooq H.

Get full text

RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AND ADVANCED KIDNEY DISEASE by Kanonidis, Evangelos, Ahmed, Amiya, Patel, Samir, Faselis, Charles, Deedwania, Prakash C., Kanonidis, Ioannis, Lam, Phillip Hong, Raman, Venkatesh K., Allman, Richard M., Fonarow, Gregg C., Ahmed, Ali

Get full text

PROLONGED CARDIOVASCULAR RISK AFTER ≥15 YEARS SMOKING CESSATION IN OLDER FORMER SMOKERS by Ahmed, Amiya, Kanonidis, Evangelos, Lam, Phillip Hong, Sheriff, Helen, Deedwania, Prakash C., Patel, Samir, Fonarow, Gregg C., Kanonidis, Ioannis, Allman, Richard, Faselis, Charles, Ahmed, Ali

Get full text

VENTRICULAR ARRHYTHMIAS IN END-STAGE HEART FAILURE PATIENTS ON AMBULATORY INOTROPIC THERAPY by Zaghlol, Raja, Ghazzal, Amre, Radwan, Sohab, Ahmed, Sara, Zaghlol, Louay, Hofmeyer, Mark, Rodrigo, Maria E., Kadakkal, Ajay, Lam, Phillip Hong, Rao, Sriram, Weintraub, William S., Molina, Ezequiel, Sheikh, Farooq H., Najjar, Samer S.

Get full text

MORTALITY IN HEART FAILURE WITH INDETERMINATE KIDNEY DISEASE by Patel, Samir, Wu, Wen-Chih Hank, Zhang, Sijian, Raman, Venkatesh K., Deedwania, Prakash C., Heidenreich, Paul A., Fink, Jeffrey Jeffrey Craig, Faselis, Charles, Lam, Phillip Hong, Sheriff, Helen, Fonarow, Gregg C., Zeng, Qing, Ahmed, Ali

Get full text

DIGOXIN INITIATION IS NOT ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: INSIGHTS FROM THE MEDICARE-LINKED OPTIMIZE-HF REGISTRY by Wopperer, Samuel, Anker, Markus, Tummala, Lakshmi Suma, Lam, Phillip Hong, Safren, Lowell, Fonarow, Gregg C., Singh, Steven, Ahmed, Ali

Get full text

POOR OUTCOMES ASSOCIATED WITH DIGOXIN DISCONTINUATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) MAY DIFFER BY BETA-BLOCKER USE by Masson, Ravi, Malik, Awais, Lam, Phillip Hong, Moore, Hans Joseph, Deedwania, Prakash, Allman, Richard, Singh, Steven, Arundel, Cherinne, Fonarow, Gregg C., Ahmed, Ali

Get full text

LOW INCOME IS LINKED TO A HIGHER RISK OF MORTALITY AND INCIDENT CARDIOVASCULAR (CV) EVENTS IN OLDER ADULTS: A 23-YEAR FOLLOW-UP OF CARDIOVASCULAR HEALTH STUDY (CHS) by Safren, Lowell, Wopperer, Samuel, Lam, Phillip Hong, Arundel, Cherinne, Faselis, Charles, Cheng, Yan, Deedwania, Prakash, Sheikh, Farooq, Howard, George, Allman, Richard, Ahmed, Ali

Get full text

THE EFFICACY OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH (SCD) IN PATIENTS WITH HEART FAILURE (HF) WITH EJECTION FRACTION (EF) 35 PERCENT OR LESS IS NOT AFFECTED BY THE METHOD USED TO ESTIMATE THE EF: INSIGHTS FROM THE SUDDEN CARDIAC DEATH IN HEART FAILURE TRIAL (SCD-HEFT) by Bonilla, Hilda Mariana Gonzalez, Ganta, Nitheesha, Greenberg, Michael, Lam, Phillip Hong, Iskandrian, Ami E., Morrissette, Jason, Goheen-Thomas, Erin, Singh, Steve, Ahmed, Ali

Get full text

HIGH-DOSE BETA-BLOCKERS (BB) AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) AND HEART RATE ≥70 BEATS PER MINUTE (BPM) by Lam, Phillip Hong, Dooley, Daniel, Tsimploulis, Apostolos, Sheriff, Helen, Faselis, Charles, Deedwania, Prakash, Fonarow, Gregg C., Ahmed, Ali

Get full text

Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508 by CHAN, K. K, HONG, P. S, TUTSCH, K, TRUMP, D. L

“…The pharmacokinetics of cyclophosphamide (CP) and several important metabolites was studied in detail in six patients receiving CP alone and with a radio- and…”
Get full text

ADVERSE OUTCOMES WITH USE OF HYDRALAZINE AND NITRATE COMBINATION THERAPY IN HOSPITALIZED OLDER NON-BLACK PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (HFREF) by Lam, Phillip Hong, Dooley, Daniel, Bayoumi, Essraa, Segal, Jonathan, Arundel, Cherinne, Filippatos, Gerasimos, Butler, Javed, Deedwania, Prakash C, Wu, Wen-Chih, White, Michel, Blackman, Marc, Morgan, Charity, Kanonidis, Ioannis, Aronow, Wilbert, Anker, Stefan, Fonarow, Gregg, Ahmed, Ali

“…Background: A combination of hydralazine and isosorbide dinitrate is recommended to self-described African American patients with HFrEF receiving optimal…”
Get full text

AMONG OLDER HEART FAILURE (HF) PATIENTS WITH IN-HOSPITAL ACUTE KIDNEY INJURY (AKI), AN IMPROVEMENT IN KIDNEY FUNCTION IS ASSOCIATED WITH A HIGHER RISK OF POST-DISCHARGE MORTALITY BUT NOT READMISSION by Lam, Phillip Hong, Dooley, Daniel, Bhyan, Poonam, Sanders, Paul W, Fonarow, Gregg, Wu, Wen-Chih, Deedwania, Prakash, Butler, Javed, Morgan, Charity, Prabhu, Sumanth, Mehta, Ravindra, Blackman, Marc, Fletcher, Ross, Aronow, Wilbert, Agarwal, Anupam, Anker, Stefan, Allman, Richard, Ahmed, Ali

“…Methods: Of the 1130 Medicare beneficiaries (mean age, 76 years; 56% women; 23% African American) with HF, no prior dialysis, and in-hospital AKI (rise in…”
Get full text

OUTCOME DIFFERENCES BETWEEN PREVALENT USERS VS. NEW USERS OF THE SAME DRUG: WHEN DRUG EFFECT OR SELECTION BIAS CANNOT EXPLAIN POOR OUTCOMES AMONG PREVALENT USERS by Faselis, Charles, Lam, Phillip Hong, Deedwania, Prakash C., Kanonidis, Ioannis, Kanonidis, Evangelos, Ahmed, Amiya, Patel, Samir, Raman, Venkatesh K., Wu, Wen-Chih, Doumas, Michael, Allman, Richard M., Fonarow, Gregg C., Ahmed, Ali

Get full text

EARLY (1-10 DAYS) READMISSION IS ASSOCIATED WITH A SIGNIFICANTLY LOWER 2-12 MONTHS POST-DISCHARGE ALL-CAUSE MORTALITY AMONG OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE WITH 30-DAY ALL-CAUSE READMISSIONS by Hong Lam, Phillip, Arundel, Cherinne, Khosla, Rahul, Morgan, Charity, Zhang, Sijian, Faselis, Charles, Wu, Wen-Chih, Blackman, Marc, Fletcher, Ross, Fonarow, Gregg, Deedwania, Prakash, Butler, Javed, Aronow, Wilbert, Banach, Maciej, Parissis, John, Anker, Stefan, Allman, Richard, Ahmed, Ali

“…Using propensity scores for 1-10 day all-cause readmission, we assembled a matched cohort of 596 pairs of patients with 1-10 day and 11-30 day all-cause…”
Get full text

Analysis of 4-hydroxycyclophosphamide by gas chromatography-mass spectrometry in plasma by Hong, P S, Chan, K K

“…A sensitive and specific method for the quantitative analysis of 4-hydroxycyclophosphamide/aldophosphamide has been developed using gas chromatography-mass…”
Get more information

Evaluating Complications of Chronic Sinusitis by Hong, Phillip, Pereyra, Charles A, Guo, Uta, Breslin, Adam, Melville, Laura

“…Chronic sinusitis is a relatively common diagnosis throughout the US. In patients with an otherwise unremarkable medical history the treatment is typically…”
Get full text